Heidi Health secures USD $16.6M in funding to free up clinicians to focus on patient care

‍Heidi, the healthcare AI company whose AI scribe is transforming how clinicians work, has raised USD $16.6M in its latest funding round. The Series A follow-on investment is led by Headline, with participation from Local Globe, Anthology (Menlo Ventures and Anthropic) and existing investors Blackbird, HESTA, Possible Ventures and Archangel Ventures. This funding will accelerate Heidi’s mission to double the world’s healthcare capacity by relieving clinicians from the administrative work that takes them away from the frontline of care.

The World Health Organization projects a shortfall of 10 million health workers by 2030. This shortage, combined with rising demand for care, has placed unprecedented pressure on clinicians and global health systems. By automating time-consuming note taking and document generation – which takes doctors over two hours a day on average – Heidi’s highly-personalised and customisable AI scribe reduces clinicians’ unsustainable workloads, empowering them to be more engaged with their patients and deliver more focused, higher quality care. Unlike many AI tools that can only operate in quiet primary care settings, Heidi works effectively in a variety of busy clinical environments – from emergency departments to surgical theatres.

Heidi will use its new funding to expand its capabilities beyond scribing. Its enhanced functionality will include creating pre-chart summaries, accessing clinical guidelines for treatments and management pathways, and engaging with patients outside the clinic. By automating these tasks, Heidi will unshackle clinicians from their computers and put them back at their patient’s side.

Since launching in February 2024, Heidi’s AI scribe has supported clinicians in over 20 million patient interactions globally. As of March 2025, clinicians now rely on Heidi in over 1 million consults every week. The scribe operates ambiently in the background, does not store session recordings and is fully compliant with region-specific privacy and data security regulations across the globe, meaning it can safely be used in all practice settings.

Dr Thomas Kelly, CEO and co-founder of Heidi, and former vascular surgical resident, commented, “Despite clinicians' passion for patient care and significant investment in their medical education, they are overwhelmed by an unsustainable administrative workload that drags them away from their clinical responsibilities. This destroys their wellbeing and drains away job satisfaction, resulting in an exodus of talented clinicians from the workforce - further reducing the capacity of our already frail healthcare systems. That’s why I founded Heidi – to free doctors from non-clinical work so they can focus on their patients and enjoy fulfilling careers in medicine.”

Taylor Brandt, Partner at Headline said, “Heidi's approach to the medical scribe market is truly differentiated. What sets Heidi apart are their bold choices: prioritising customisation over complex integrations, their global-first strategy, and building a product-led motion out of Australia that rivals tech giants like Canva and Atlassian. In just one year, they're already facilitating one million consultations weekly across five countries which far outstrips other AI scribe offerings—an extraordinary testament to how perfectly they've addressed clinicians' needs.”

Ferdi Sigona, Partner at LocalGlobe said, "Thanks to its widespread clinical usage, constant feedback, and rapid iteration, Heidi has emerged as the best product in its category. As medical scribes fast become one of the most impactful applications of AI, we believe Heidi is leading the way toward a future where agentic AI will transform healthcare further still. We couldn’t be more excited to back a team making such a meaningful difference to clinicians’ lives and patient care."

Heidi has become the AI scribe of choice for the individual clinician and healthcare systems, with significant adoption in the US, UK, Canada and Australia, and growing uptake in the EU. Most recently, Heidi was selected by Modality Partnership, the NHS's largest GP super-partnership, in the UK’s largest deployment of ambient AI in a clinical setting; Beth Israel, the largest health system in Massachusetts, USA; ForHealth, the largest multi-disciplinary healthcare network in Australia; and Tamaki Health, the largest primary healthcare provider in New Zealand.

‍

‍UK Media contact

Rachel Gurney

+44(0)7738226521 / Rachel@founderscomms.co

‍

Jenna Birch

810-599-1476 / jenna@sisubrandpr.com

‍

Leah Mahtani

+61451408219 / leah@heidihealth.com